The Biotechnology industry investigates and capitalises on the commercial applications of biological manipulation. It is fast becoming a prominent part of the UK life sciences scene alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it increasingly difficult to identify the boundaries between them. The industry relies on third-party financing, so the economic downturn posed significant funding challenges. Low business confidence made private financiers uncertain about investing in risky research and development (R&D) projects during many years of the period. This dampened growth, but could not contain it.
Biotechnology uses scientific principles to create technological applications that use biological systems, living organisms or derivatives thereof to make or modify products or processes. The industry focuses on medicinal, industrial and agricultural biotechnology applications.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.